Abstract Haem oxygenase 1 (HO-1), an inducible enzyme responsible for the breakdown of
haem, is primarily considered an antioxidant, and has long been overlooked by …

Over the past century, solid organ transplantation has been improved both at a surgical and
postoperative level. However, despite the improvement in efficiency, safety, and survival, we …

Cell therapy is a promising strategy for treating patients suffering from autoimmune or
inflammatory diseases or receiving a transplant. Based on our preclinical studies, we have …

The pursuit of clinical transplant tolerance has led to enhanced understanding of
mechanisms underlying immune regulation, including the characterization of immune …

Dendritic cells (DCs) as highly efficient antigen-presenting cells are at the interface of innate
and adaptive immunity. As such, they are key mediators of immunity and antigen-specific …

Kidney transplant survival is shortened by chronic rejection and side effects of standard
immunosuppressive drugs. Cell-based immunotherapy with tolerogenic dendritic cells has …

Dendritic cells (DC s) are specialized cells of the innate immune system that are
characterized by their ability to take up, process and present antigens (Ag) to effector T cells …

Myeloid regulatory cell-based therapy has been shown to be a promising cell-based
medicinal approach in organ transplantation and for the treatment of autoimmune diseases …

Considering the substantial role played by dendritic cells (DCs) in the immune system to
bridge innate and adaptive immunity, studies on DC-mediated immunity toward biomaterials …

Myeloid cells play a pivotal role in regulating innate and adaptive immune responses. In
inflammation, autoimmunity, and after transplantation, myeloid cells have contrasting roles …